SCHEMBL22902813

SCHEMBL22902813

COc1cccc2cc(CN)c(N)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.53
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
NQO2 P16083 4/20 0.43
CYP3A4 P08684 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HPGDS O60760 2/20 0.42
TLR8 Q9NR97 2/20 0.41
PDE10A Q9Y233 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3208099 0.84 MCHR1 (0.49) MCHR1PDE3BPDE3ANQO2CYP3A4
SCHEMBL3221311 0.84 MCHR1 (0.49) MCHR1PDE3BPDE3ANQO2TLR8
SCHEMBL1655885 0.78 MCHR1 (0.56) MCHR1PDE3BPDE3ANQO2CYP3A4
SCHEMBL4714041 0.76 PDE10A (0.47) MCHR1TLR8PDE10AKDM4EMAPT
SCHEMBL4185069 0.76 PDE4B (0.43) MCHR1PDE3BPDE3ACYP3A4ALDH1A1
SCHEMBL4717995 0.76 PDE10A (0.46) MCHR1TLR8PDE10A
SCHEMBL4714239 0.75 HSP90AA1 (0.41) MCHR1NQO2TLR8KDM4E
SCHEMBL4716953 0.75 MCHR1 (0.39) MCHR1NQO2CYP3A4TDP1HPGDS
SCHEMBL22902818 0.74 MCHR1 (0.51) MCHR1PDE3BPDE3ANQO2CYP3A4
SCHEMBL4718160 0.74 ADCY10 (0.46) NQO2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011724-A1 TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-01-21 WO disclosed